Repligen Corporation (RGEN) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.45	$0.54	+20.0%	—	$204.1M	—
Q1 26	$0.39	$0.48	+23.1%	—	$194.3M	—
Q4 25	$0.44	$0.49	+11.4%	—	$197.9M	—
Q3 25	$0.42	$0.46	+9.5%	—	$188.8M	—
Q2 25	$0.39	$0.37	-5.1%	—	$182.4M	—
Q1 25	$0.35	$0.39	+11.4%	—	$169.2M	—
Q4 24	$0.41	$0.44	+7.3%	—	$167.5M	—
Q3 24	$0.33	$0.43	+30.3%	—	$154.9M	—
Q2 24	$0.33	$0.33	0.0%	—	$158.8M	—
Q1 24	$0.3	$0.28	-6.7%	—	$153.2M	—
Q4 23	$0.34	$0.33	-2.9%	—	$155.7M	—
Q3 23	$0.16	$0.23	+43.8%	—	$141.2M	—
Q2 23	$0.48	$0.53	+10.4%	—	$159.2M	—
Q1 23	$0.59	$0.64	+8.5%	—	$165.4M	—
Q4 22	$0.58	$0.68	+17.2%	—	$186.8M	—
Q3 22	$0.68	$0.77	+13.2%	—	$200.7M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$0.87	—	—	$738.3M	—
FY24	—	-$0.46	—	—	$634.4M	—
FY23	—	$0.64	—	—	$632.4M	—
FY22	—	$3.35	—	—	$801.5M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$104.5M	$141.2M	$194M	$270.2M	$366.3M	$670.5M	$801.5M	$632.4M	$634.4M	$738.3M
YoY change	+25.1%	+35.1%	+37.4%	+39.3%	+35.5%	+83.1%	+19.5%	-21.1%	+0.33%	+16.4%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	104.5M	141.2M	194M	270.2M	366.3M	670.5M	801.5M	632.4M	634.4M	738.3M
Cost of revenue	47.1M	67M	86.5M	119.1M	156.6M	279.3M	345.8M	353.9M	359.8M	352M
Gross profit	57.4M	74.2M	107.5M	151.1M	209.6M	391.3M	455.7M	278.4M	274.6M	386.2M
Gross margin	54.9%	52.5%	55.4%	55.9%	57.2%	58.3%	56.9%	44%	43.3%	52.3%
Research & development	7.4M	8.7M	15.8M	19.4M	20.2M	34.3M	43.9M	42.7M	43.2M	54.2M
Selling, general & administrative	30.9M	51.5M	65.7M	95.6M	119.6M	183.9M	215.8M	218.6M	263.4M	290.5M
Operating expenses	38.2M	60.2M	81.5M	115.1M	139.8M	218.1M	259.8M	261.3M	306.6M	344.7M
Operating income	19.2M	14M	26M	36.1M	69.8M	173.1M	195.9M	17.1M	-31.9M	41.6M
Operating margin	18.4%	9.92%	13.4%	13.4%	19.1%	25.8%	24.4%	2.71%	-5.03%	5.63%
Non-operating income, net	-3.8M	-316K	2.2M	-640K	1.5M	-6.9M	26.2M	50.2M	27.5M	44M
Pretax income	11.7M	7.2M	21.4M	26.2M	59.2M	153.5M	219.1M	56.7M	-27M	62.4M
Income tax	11K	-21.1M	4.8M	4.7M	-709K	25.3M	33.2M	21.1M	-1.5M	13.5M
Net income	11.7M	28.4M	16.6M	21.4M	59.9M	128.3M	186M	35.6M	-25.5M	48.9M
Net margin	11.2%	20.1%	8.56%	7.92%	16.4%	19.1%	23.2%	5.63%	-4.02%	6.62%
EBITDA	23.7M	23.8M	42M	51M	95.3M	209M	235.6M	85.7M	47.6M	139.7M
EPS	0.35	0.74	0.38	0.44	1.14	2.33	3.35	0.64	-0.46	0.87
Diluted EPS	0.34	0.72	0.37	0.44	1.11	2.24	3.24	0.63	-0.46	0.86

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	141.2M	155.7M	153.2M	158.8M	154.9M	167.5M	169.2M	182.4M	188.8M	197.9M	194.3M	204.1M
Cost of revenue	104.6M	88.1M	76.4M	77.3M	77.4M	128.7M	78.4M	91.2M	88.3M	94.1M	86M	94.1M
Gross profit	36.6M	67.6M	76.8M	81.5M	77.5M	38.8M	90.8M	91.1M	100.5M	103.8M	108.3M	110M
Gross margin	25.9%	43.4%	50.1%	51.3%	50%	23.2%	53.6%	50%	53.2%	52.5%	55.7%	53.9%
Research & development	10.6M	10.3M	11.2M	10.6M	9.7M	11.7M	12.9M	14M	14.2M	13.1M	14.5M	14.4M
Selling, general & administrative	55.6M	57.5M	61.8M	65.5M	75.6M	60.5M	71.3M	71.2M	73.7M	74.4M	76.5M	76.6M
Operating expenses	66.2M	67.8M	73M	76.1M	85.3M	72.2M	84.2M	85.2M	87.8M	87.5M	91M	91M
Operating income	-29.6M	-190K	3.8M	5.5M	-7.8M	-33.3M	6.6M	6M	12.7M	16.3M	17.3M	19M
Operating margin	-21%	-0.12%	2.45%	3.44%	-5.06%	-19.9%	3.89%	3.27%	6.71%	8.26%	8.9%	9.31%
Non-operating income, net	41.8M	-727K	5.5M	9.2M	12.2M	575K	7M	18M	10.3M	8.7M	-9.5M	1.2M
Pretax income	11.4M	-8.8M	3.7M	9M	-1.1M	-38.6M	7.9M	18.2M	17.1M	19.1M	1.8M	14.2M
Income tax	-5.5M	16.7M	399K	3.3M	-495K	-4.7M	2.1M	3.3M	2.2M	5.8M	-6.6M	9.1M
Net income	16.9M	-25.5M	3.3M	5.7M	-654K	-33.9M	5.8M	14.9M	14.9M	13.3M	8.3M	5M
Net margin	12%	-16.4%	2.15%	3.6%	-0.42%	-20.2%	3.45%	8.15%	7.9%	6.71%	4.29%	2.45%
EBITDA	-9.3M	16.9M	16.6M	17.3M	3.5M	-3M	29.1M	33.8M	35.9M	40.9M	40.7M	42.1M
EPS	0.3	-0.46	0.04	0.1	-0.01	-0.6	0.1	0.26	0.27	0.24	0.15	0.09
Diluted EPS	0.3	-0.46	0.04	0.1	-0.01	-0.6	0.1	0.26	0.26	0.23	0.15	0.09

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	1B	—	—	—	10.1B	14.6B	9.4B	10B	8.1B	9.2B	11B
Enterprise value	988.2M	—	—	—	9.6B	14.3B	9.2B	10B	8B	9.1B	10.6B
Shares outstanding	33.6M	38.2M	43.8M	48.3M	52.6M	55M	55.5M	55.7M	55.9M	56.2M	56.2M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	88.6	—	—	—	168.1	113.6	50.5	281.4	—	188.5	263.4
P/S	9.9	—	—	—	27.5	21.7	11.7	15.8	12.7	12.5	13.6
P/B	6.13	—	—	—	6.59	8.33	4.91	5.1	4.08	4.38	5.07
EV/EBITDA	41.7	—	—	—	101	68.6	39	116.4	167.6	65.4	73.5
EV/Sales	9.45	—	—	—	26.3	21.4	11.5	15.8	12.6	12.4	13.5
Earnings yield	1.13%	—	—	—	0.6%	0.88%	1.98%	0.36%	—	0.53%	0.38%
FCF yield	0.31%	—	—	—	0.36%	0.33%	0.41%	0.75%	1.77%	1%	1.04%
PEG	—	—	—	—	—	—	—	—	—	—	-4.03

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	54.9%	52.5%	55.4%	55.9%	57.2%	58.3%	56.9%	44%	43.3%	52.3%	53.9%
Operating margin	18.4%	9.92%	13.4%	13.4%	19.1%	25.8%	24.4%	2.71%	-5.03%	5.63%	9.31%
Net margin	11.2%	20.1%	8.56%	7.92%	16.4%	19.1%	23.2%	5.63%	-4.02%	6.62%	5.29%
ROE	6.92%	4.79%	2.7%	2.02%	3.92%	7.33%	9.73%	1.81%	-1.29%	2.32%	1.99%
ROA	4.04%	3.81%	2.15%	1.53%	3.15%	5.44%	7.35%	1.26%	-0.9%	1.66%	1.4%
ROIC	15.7%	2.71%	3.84%	3.72%	6.42%	9.56%	9.72%	0.56%	-1.68%	1.61%	2.61%
Return on tangible assets	10.6%	-14.1%	-11.1%	56.1%	65.1%	-347.5%	187.2%	82.7%	90.7%	-95.1%	156.3%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	8.74	9.63	2.12	13.3	2.83	2.48	2.47	6.74	8.41	8.37	9.05
Quick ratio	7.57	8.08	1.8	12.1	2.53	1.99	1.88	5.51	7.28	7.12	7.64
Debt / equity	0.56	0.17	0.17	0.25	0.18	0.21	0.22	0.36	0.35	0.33	0.33
Debt / assets	0.33	0.13	0.13	0.19	0.14	0.16	0.17	0.25	0.24	0.23	0.23
Net debt / EBITDA	-1.96	-3.13	-2.15	-5.2	-4.64	-1.14	-0.85	-0.46	-1.49	-0.56	-0.75
Interest coverage	4.1	2.13	4.2	3.81	6.5	14.6	189.6	23.7	-0.3	3.9	3.35
Effective tax rate	0.09%	0%	22.5%	18.1%	0%	16.4%	15.1%	37.2%	0%	21.6%	20.3%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	3.11	3.69	4.43	5.59	6.97	12.2	14.5	11.3	11.3	13.1	13.9
EPS (basic)	0.35	0.74	0.38	0.44	1.14	2.33	3.35	0.64	-0.46	0.87	0.87
EPS (diluted)	0.34	0.72	0.37	0.44	1.11	2.24	3.24	0.63	-0.46	0.86	0.72
Book value per share	5.03	15.5	14.1	21.9	29.1	31.8	34.5	35.3	35.3	37.5	37.4
FCF per share	0.1	0.31	0.43	0.91	0.69	0.87	0.7	1.34	2.55	1.63	1.94
Cash per share	4.22	4.54	4.43	10.9	13.6	11	11.2	13.5	13.5	13.7	14.4
Capex per share	0.13	0.14	0.24	0.38	0.43	1.22	1.53	0.65	0.46	0.04	0.03

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	4.09%	3.86%	5.48%	6.85%	6.13%	10%	10.6%	5.73%	4.05%	0.3%	0.23%
Capex / operating cash flow	40%	25.5%	30%	41.8%	31.7%	63.3%	49.4%	26.6%	15.6%	1.88%	1.34%
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$141.2M	$155.7M	$153.2M	$158.8M	$154.9M	$167.5M	$169.2M	$182.4M	$188.8M	$197.9M	$194.3M	$204.1M
YoY change	-29.7%	-16.6%	-7.38%	-0.21%	+9.69%	+7.58%	+10.4%	+14.8%	+21.9%	+18.1%	+14.8%	+11.9%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	141.8M	173.8M	193.8M	528.4M	717.3M	603.8M	623.8M	751.3M	757.4M	767.6M
Receivables	15.2M	27.6M	33M	43.1M	71.4M	117.4M	116.2M	124.2M	134.1M	158.6M
Inventory	24.7M	39M	42.3M	54.8M	95M	184.5M	238.3M	202.3M	143M	170.5M
Total current assets	184.2M	242.8M	275.7M	641.8M	902.4M	931.7M	998.1M	1.1B	1.1B	1.1B
Property, plant & equipment	15M	21.7M	31.4M	73.4M	91.3M	225.8M	314.1M	321.3M	332.4M	305.4M
Goodwill & intangibles	178.7M	944.2M	924.3M	1.4B	1.8B	2.4B	2.4B	2.8B	2.9B	3B
Total assets	288.9M	743.5M	774.6M	1.4B	1.9B	2.4B	2.5B	2.8B	2.8B	2.9B
Accounts payable	5.1M	7.3M	10.5M	11.4M	16.9M	36.2M	27.6M	19.6M	32.1M	30M
Short-term debt	—	—	103.5M	3.6M	249M	263.6M	291.6M	75.1M	15.1M	21.6M
Total current liabilities	21.1M	25.2M	129.8M	48.3M	319M	375.3M	404.2M	164.9M	126.8M	135.8M
Long-term debt	95.3M	99.3M	0	259.8M	26.4M	102.5M	131.4M	636.7M	671.1M	668.4M
Total liabilities	120.1M	152M	159.1M	340.3M	373.7M	608.3M	620.9M	866.3M	856.9M	843.6M
Shareholders' equity	168.8M	591.5M	615.6M	1.1B	1.5B	1.8B	1.9B	2B	2B	2.1B
Total debt	95.3M	99.3M	103.5M	263.3M	275.4M	366.1M	423M	711.8M	686.2M	689.9M
Net debt	-27M	-74.5M	-90.3M	-265.1M	-441.9M	-237.8M	-100.5M	-39.5M	-71.1M	123.9M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	630.8M	751.3M	780.6M	809.1M	784M	757.4M	697.2M	708.9M	748.7M	767.6M	784.5M	810.4M
Receivables	106.2M	124.2M	115.8M	123.2M	129M	134.1M	147.4M	157M	149M	158.6M	151.6M	157.7M
Inventory	211.4M	202.3M	198M	190.5M	182.5M	143M	153.1M	155.9M	160.3M	170.5M	179.3M	186.6M
Total current assets	978.5M	1.1B	1.1B	1.2B	1.1B	1.1B	1B	1.1B	1.1B	1.1B	1.2B	1.2B
Property, plant & equipment	318.1M	321.3M	339.6M	335.4M	329.1M	332.4M	324.5M	320.4M	312.3M	305.4M	287.1M	283.1M
Goodwill & intangibles	2.4B	2.8B	2.7B	2.7B	2.7B	2.9B	3B	3B	3B	3B	3B	2.9B
Total assets	2.5B	2.8B	2.8B	2.9B	2.8B	2.8B	2.9B	2.9B	2.9B	2.9B	2.9B	3B
Accounts payable	19M	19.6M	18.7M	20.9M	21.4M	32.1M	26.9M	25.6M	29.4M	30M	34.7M	33.2M
Short-term debt	289.3M	75.1M	79.3M	81.6M	12.2M	15.1M	15.2M	16M	19.3M	21.6M	21.1M	19.3M
Total current liabilities	363.4M	164.9M	178.3M	174.3M	108.4M	126.8M	152M	123M	131.1M	135.8M	126.2M	132.7M
Long-term debt	130.6M	636.7M	658.5M	661.2M	660.3M	671.1M	668.5M	670M	669.6M	668.4M	666.5M	671.6M
Total liabilities	525.6M	866.3M	878.7M	875.6M	814M	856.9M	866.7M	839.9M	840.6M	843.6M	825.3M	838.1M
Shareholders' equity	2B	2B	2B	2B	2B	2B	2B	2.1B	2.1B	2.1B	2.1B	2.1B
Total debt	419.9M	711.8M	737.7M	742.9M	672.5M	686.2M	683.7M	686.1M	688.9M	689.9M	687.6M	690.9M
Net debt	-210.9M	-39.5M	-42.9M	-66.3M	-111.5M	-71.1M	-13.5M	-22.8M	-59.9M	123.9M	105M	84.2M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	11.7M	28.4M	16.6M	21.4M	59.9M	128.3M	186M	35.6M	-25.5M	48.9M
Depreciation & amortization	5.3M	10.5M	15.8M	20.9M	27.1M	38.4M	51M	68.6M	86.6M	97M
Stock-based compensation	4.6M	6.7M	10.2M	12.8M	17M	27.5M	27.3M	25.6M	48.1M	32.6M
Change in working capital	-12.3M	-3.6M	-11.5M	-19.9M	-41.1M	-115.1M	-64.2M	32.3M	53.3M	-54.9M
Operating cash flow	10.7M	21.4M	35.4M	44.3M	70.9M	106M	171.7M	136.1M	164.1M	117.4M
Capital expenditure	-4.3M	-5.5M	-10.6M	-18.5M	-22.5M	-67.1M	-84.8M	-36.2M	-25.7M	-2.2M
Investing cash flow	-49.2M	-98.2M	-10.6M	-200.7M	-197.5M	-217M	-184.7M	-120.5M	-79.2M	-275.2M
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	0	0	-14.4M	0	0
Financing cash flow	110.3M	127.6M	-22K	368.7M	297.8M	-3M	-17.1M	247.9M	-87.2M	-18.4M
Net change in cash	71.8M	50.7M	24.8M	212.4M	171.1M	-113.9M	-30.1M	263.5M	-2.2M	-176.2M
Free cash flow	3.2M	12M	18.7M	44.1M	36.3M	47.7M	38.7M	74.9M	142.5M	91.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	—	—	—	—	—	—	—	—	14.9M	13.3M	8.3M	5M
Depreciation & amortization	—	—	—	—	—	—	—	—	24.4M	24.6M	24.5M	23.8M
Stock-based compensation	—	—	—	—	—	—	—	—	9M	8M	8.3M	8M
Change in working capital	—	—	—	—	—	—	—	—	4.7M	-24.3M	-7.3M	-21.1M
Operating cash flow	—	—	—	—	—	—	—	—	48.1M	25.7M	28.3M	32.8M
Capital expenditure	—	—	—	—	—	—	—	—	-684K	-156K	-237K	-735K
Investing cash flow	256K	-158.8M	0	0	0	-54.8M	-69.7M	-234K	-684K	-530K	722K	2.8M
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	—	—	—	—	—	—	—	—	-917K	-839K	-5.5M	-6.3M
Net change in cash	256K	-158.8M	0	0	0	-54.8M	-69.7M	-234K	46.5M	24.3M	23.5M	29.3M
Free cash flow	—	—	—	—	—	—	—	—	42.7M	17.4M	23.3M	26.7M

Repligen Corporation Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement